In the first week of December, the company Ovohorse was awarded in the “Genetics” category thanks to the outstanding work and research of Ovoclone: animal cloning. The award was granted by the Institute of Professional and Business Excellence.
The gala, known as The European Awards, brought together the winners at the prestigious Ritz Hotel in Paris to present the awards for professional excellence and business innovation.
Ovoclone was born from the experience of the professionals who make up the OVO Group; a team of more than 150 specialists including embryologists, doctors, veterinarians, and researchers. Today, it is one of the leading groups in reproductive medicine and cell cryopreservation.
The scientific team of Ovoclone and Ovohorse has succeeded in implementing animal cloning in Spain. This technique makes it possible to clone a genetically healthy animal identical to an existing one. To carry out cloning, it is necessary to perform a biopsy of the animal in order to obtain the cells required to start the replication process. Once the sample has been obtained, the professionals at Ovoclone take care of the entire process, cultivating and developing the cells to obtain an embryo identical to the original animal (dog, cat, horse, or camel). Thanks to their expertise in cell cryopreservation, the Ovohorse and Ovoclone team also maintains a genetic cryopreservation bank of samples to preserve them for future use.
Ovoclone is the perfect combination of high-quality technology, highly qualified professionals, and years of experience in assisted reproduction.
The innovative project is led by the embryologist and CEO of the OVO Group, Enrique Criado Scholz. His professional career has been distinguished by numerous achievements in the field of assisted human reproduction. He has worked as an embryologist in the best clinics in Italy and the United States, training in the latest laboratory techniques and conducting research that has improved cell freezing protocols. “We are constantly innovating, developing new procedures and improving laboratory protocols to optimise the results of genetic preservation and animal cloning,” says the CEO of Ovohorse and Ovoclone, Enrique Criado Scholz.
The Ovohorse project is made possible thanks to the partnership and expertise of Enrique Criado Scholz, embryologist, laboratory director and CEO of the OVO Group, and Andrés Gambini, scientific director of Ovohorse, with more than 12 years of experience in equine assisted reproduction.